Iowa lawmakers are considering a bill that would require the state’s public health medical director to sign a standing order allowing pharmacists to dispense ivermectin without a prescription. The bill,introduced in January 2024,has sparked debate over access to the drug and its potential uses. The Des Moines Register first reported on the legislation.
Ivermectin is an antiparasitic drug primarily used to treat infections in animals. While the Food and Drug governance (FDA) has approved ivermectin for certain parasitic infections in humans, it has not authorized or approved its use for treating or preventing COVID-19. Despite this, the drug gained prominence during the pandemic as some promoted it as a potential treatment, leading to increased demand and reports of misuse.
proponents of the bill argue that individuals should have the right to access medications they believe will benefit their health, even if those uses are not officially approved. They contend that pharmacists are qualified healthcare professionals capable of assessing a patient’s needs and dispensing medications appropriately. KCRG reports that supporters believe the bill expands healthcare access.
however, opponents, including medical professionals and public health officials, express concerns about the safety and efficacy of using ivermectin for unapproved purposes. They point to the FDA’s warnings about potential side effects, including nausea, vomiting, diarrhea, liver damage, and neurological problems. The Centers for Disease Control and Prevention (CDC) also cautions against self-medicating with ivermectin.
The bill has passed the Iowa House and is now under consideration in the senate. If enacted, Iowa would join a small number of states considering or implementing similar measures regarding access to ivermectin. The debate highlights the ongoing tension between individual liberty, medical authority, and public health concerns. as of January 20, 2026, the bill’s future remains uncertain.
